Solana Company
NASDAQ:HSDTMedical - Devices
+$0.01 today
- Market cap
- $95.17M
- Beta
- 1.03
- P/E (TTM)
- -0.9
- EPS (TTM)
- -$1.78
Volume 0.23M
Average 0.38M
HSDT Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Solana CompanyNASDAQ: HSDT
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization outflow shrinks to $0
Q1 FY2026 depreciation & amortization was $0, compared with $8K a year earlier. Trailing-twelve-month depreciation & amortization was $672K. Over 3 fiscal years it compounded at +30.5% a year.
Context
- Depreciation & amortization amounted to 11.3% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near $0 or moves back toward the trailing-twelve-month quarterly average of $168K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 680K USD
- Year-over-year change
- +1033.3%
- 4-year CAGR
- +16.1%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 680K | +1033.3% |
| FY2024 | 2024-12-31 | 60K | -63.0% |
| FY2023 | 2023-12-31 | 162K | -47.1% |
| FY2022 | 2022-12-31 | 306K | -18.2% |
| FY2021 | 2021-12-31 | 374K | — |
Depreciation & Amortization vs competitors
How HSDT compares with its peers on the latest reported figures
- HSDT's LTM Mar 2026 depreciation & amortization of $672K is the 8th largest of the 11 companies compared; the peer median is $3.19M.
- Its year-over-year change of +1192.3% is the highest of 11, against a peer median of +1.0%.
- Depreciation & amortization amounts to 7.0% of revenue for HSDT, versus a peer median of 4.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $22.58M | +148.0% | +52.4% | 15.6% | |
| LTM Mar 2026 | $20.37M | -2.6% | -4.2% | 5.8% | |
| LTM Mar 2026 | $13.25M | +2.4% | -0.2% | 9.3% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| LTM Mar 2026 | $3.65M | +35.4% | +111.4% | 589.8% | |
| LTM Mar 2026 | $2.74M | +63.9% | -5.7% | 2.3% | |
| LTM Mar 2026 | $1.11M | +12.8% | +23.1% | 1.5% | |
| LTM Mar 2026 | $672K | +1192.3% | +30.5% | 7.0% | |
| LTM Mar 2026 | $589K | -20.5% | +16.3% | 1.3% | |
| LTM Mar 2026 | $499.37K | -27.3% | -29.2% | 2.6% | |
| LTM Mar 2026 | $103K | -90.0% | +10.5% | 0.2% | |
| Peer median (excluding HSDT) | $3.19M | +1.0% | +5.5% | 4.2% | |
Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (18.13M) | (14.07M) | (8.85M) | (11.74M) | (40.89M) |
| Depreciation & Amortization | 374K | 306K | 162K | 60K | 680K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 1.63M | 2.52M | 9.25M |
| Change in Working Capital | 127K | (1.31M) | (311K) | (8K) | 230K |
| Accounts Receivables | 1K | (103K) | (291K) | (5K) | 0 |
| Inventory | (87K) | (111K) | 137K | (607K) | (85K) |
| Accounts Payables | 369K | (418K) | (103K) | 344K | 1.02M |
| Other Working Capital | (156K) | (674K) | (54K) | 260K | (702K) |
| Other Non-Cash Items | 4.24M | 762K | (3.05M) | (1.87M) | 14.22M |
| Operating Cash Flow | (13.39M) | (14.31M) | (10.42M) | (11.04M) | (16.51M) |
| Capital Expenditures | (54K) | (17K) | (29K) | (5K) | (44.78M) |
| Acquisitions (Net) | 0 | 6K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | (426.53M) |
| Investing Cash Flow | (56K) | (11K) | (29K) | (5K) | (426.53M) |
| Debt Repayment | 0 | 0 | 0 | 0 | (680K) |
| Common Stock Issued | 21.13M | 17.87M | 1.08M | 6.95M | 467.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 3.99M | (17.11M) |
| Financing Cash Flow | 21.13M | 17.87M | 1.08M | 6.95M | 449.24M |
| Effect of Forex Changes | (8K) | (4K) | 1K | (2K) | 1K |
| Net Change in Cash | 7.67M | 3.54M | (9.37M) | (4.09M) | 6.19M |
| Free Cash Flow | (13.44M) | (14.33M) | (10.45M) | (11.05M) | (61.29M) |
Solana Company
NASDAQ:HSDT
Intrinsic Alpha fair value
Locked
Current Price
$1.63
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.